Home
Bios Equity COF, Director: Actuate Therapeutics ACTU Buy · Filed 25/06/30
Trade details
- Type
- Insider buy
- Amount
- $499,996
- Shares · price
- 71,428 sh · $7.00 a share
- Held after
- 196,428 sh
- Person
- Bios Equity COFDirector
- Trade date
- 25/06/27
- Filed
- 25/06/30
- Days to filing
- 3 days
First buy since 2023
- Insiders buying this week
- 24 insiders
- Holding change
- +57.1%
Actuate Therapeutics trades, last 26 weeks
What else happened in Actuate Therapeutics around then
Filed or reported within 30 days of the trade day · 25/05/28~25/07/27Bios Equity COF's recent trades
- Bios Equity COF
SellActuate Therapeutics
SellActuate Therapeutics
ACTU
$138.9K
17,361 sh
$138.9K
Filed 24/08/20
Traded 24/08/14
- Bios Equity COF
SellActuate Therapeutics
SellActuate Therapeutics
ACTU
$42.5K
5,314 sh
$42.5K
Filed 24/08/20
Traded 24/08/14
- Bios Equity COF
SellActuate Therapeutics
SellActuate Therapeutics
ACTU
$18.6K
2,324 sh
$18.6K
Filed 24/08/20
Traded 24/08/14
- Bios Equity COF
BuyActuate Therapeutics
BuyActuate Therapeutics
ACTU
$3M
375,000 sh
$3M
Filed 24/08/14
Traded 24/08/14
- Bios Equity COF
BuyActuate Therapeutics
BuyActuate Therapeutics
ACTU
$1M
125,000 sh
$1M
Filed 24/08/14
Traded 24/08/14